| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.087 | 0.08 |